产品名称
抗-小鼠IgG2a (γ-链特异性)-过氧化物酶 兔抗, affinity isolated antibody, lyophilized powder
biological source
rabbit
conjugate
peroxidase conjugate
antibody form
affinity isolated antibody
antibody product type
secondary antibodies
clone
polyclonal
form
lyophilized powder
species reactivity
mouse
technique(s)
immunohistochemistry: suitable
indirect ELISA: suitable
western blot: suitable
shipped in
wet ice
storage temp.
2-8°C
target post-translational modification
unmodified
Quality Level
Biochem/physiol Actions
本产品采用单特异性抗血清，通过免疫亲和色谱法制备，使用小鼠IgG偶联琼脂糖珠，然后进行固相吸附，以去除任何不希望的反应。通过免疫电泳分析，产生了针对抗过氧化物酶、抗兔血清、小鼠IgG和小鼠血清的单一沉淀弧。通过ELISA证实了特异性，与其他小鼠或重链或轻链同种型的交叉反应性低于1%。
Disclaimer
除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
General description
免疫球蛋白G（IgG）是免疫球蛋白家族的一部分。它由恒定（C）区的γ重链组成，并在血清中广泛表达。IgG是150kDa的单体，具有两条相同的重链和两条相同的轻链，分子量分别为50kDa和25kDa。该抗体的一级结构还包含连接两条重链、连接重链和轻链，并位于链内的二硫键。母体IgG是唯一能通过胎盘转运至胎儿的抗体。它对婴儿进行被动免疫。IgG 可进一步分为四种亚型，即IgG1、IgG2、IgG3 和 IgG4，而这四种亚型所含的不同重链分别称为 γ1、 γ2、 γ3 和 γ4。IgG2参与对细菌荚膜多糖抗原的免疫反应。它的缺乏与细菌感染的易感性增加有关。
抗体类型：IgG
Immunogen
小鼠IgG2a重链
Physical form
在0.02 M磷酸钾、0.15 M氯化钠（pH 7.2）和10 mg/mL牛血清白蛋白（BSA）中提供-无免疫球蛋白和蛋白酶
Preparation Note
用1.0 mL去离子水（或等效物）复溶。
未找到合适的产品？
试试我们的产品选型工具.
signalword
Warning
hcodes
Hazard Classifications
Skin Sens. 1
存储类别
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
常规特殊物品
此项目有
Maartje R Inklaar et al.
NPJ vaccines, 8(1), 186-186 (2023-12-13)
Malaria transmission-blocking vaccines (TBVs) aim to induce antibodies that block Plasmodium parasite development in the mosquito midgut, thus preventing mosquitoes from becoming infectious. While the Pro-domain and first of fourteen 6-Cysteine domains (Pro-D1) of the Plasmodium gamete surface protein Pfs230
Adrian Rice et al.
Frontiers in immunology, 13, 910136-910136 (2022-08-02)
We assessed if immune responses are enhanced in CD-1 mice by heterologous vaccination with two different nucleic acid-based COVID-19 vaccines: a next-generation human adenovirus serotype 5 (hAd5)-vectored dual-antigen spike (S) and nucleocapsid (N) vaccine (AdS+N) and a self-amplifying and -adjuvanted
Adrian Rice et al.
Scientific reports, 11(1), 14917-14917 (2021-07-23)
We have developed a COVID-19 vaccine, hAd5 S-Fusion + N-ETSD, that expresses SARS-CoV-2 spike (S) and nucleocapsid (N) proteins with modifications to increase immune responses delivered using a human adenovirus serotype 5 (hAd5) platform. Here, we demonstrate subcutaneous (SC) prime and SC
Karen Cortés-Sarabia et al.
Applied microbiology and biotechnology, 104(14), 6173-6183 (2020-05-29)
Bacterial vaginosis is one of the most frequent vaginal infections. Its main etiological agent is Gardnerella vaginalis, which produces several virulence factors involved in vaginal infection and colonization, in particular, sialidase (SLD), a potential clinical biomarker that participates in immune
Human placental Fc receptors and the transmission of antibodies from mother to fetus.
Simister NE and Story CM
Journal of Reproductive Immunology, 37(1), 1-23 (1997)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持